Compound Summary
Compound Information
152121-30-7
Compound Name: | 152121-30-7 |
Compound CID: | 5169 |
Synonyms: | 152121-30-7 SB 202190 SB202190 SB-202190 FHPI More... |
Iupac Name: | 4-[4-(4-fluorophenyl)-5-pyridin-4-yl-1H-imidazol-2-yl]phenol |
InChI: | InChI=1S/C20H14FN3O/c21-16-5-1-13(2-6-16)18-19(14-9-11-22-12-10-14)24-20(23-18)15-3-7-17(25)8-4-15/h1-12,25H,(H,23,24) |
InChIKey: | QHKYPYXTTXKZST-UHFFFAOYSA-N |
Canonical Smiles: | C1=CC(=CC=C1C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F)O |
Isomeric Smiles: | C1=CC(=CC=C1C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F)O |
Molecular Weight: | 331.3 |
Molecular Formula: | C20H14FN3O |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
152121-30-7
Molecular Weight: | 331.3 |
Molecular Formula: | C20H14FN3O |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 3 |
Heavy Atom Count: | 25 |
Complexity: | 415 |
Synonyms
152121-30-7
| 152121-30-7 | 152121-30-7 |
|---|---|
152121-30-7 |
SB 202190 |
SB202190 |
SB-202190 |
FHPI |
4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole |
SB202190 (FHPI) |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole |
UNII-PVX798P8GI |
CHEBI:79090 |
4-(4-(4-fluorophenyl)-5-(pyridin-4-yl)-1H-imidazol-2-yl)phenol |
Phenol, 4-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl- |
PVX798P8GI |
C20H14FN3O |
4-4-(4-fluorophenyl)-5-(pyridin-4-yl)-1H-imidazol-2-ylphenol |
MFCD00941964 |
4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole |
4-4-(4-Fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-ylphenol |
4-5-(4-fluorophenyl)-4-(pyridin-4-yl)-1H-imidazol-2-ylphenol |
4-(5-(4-fluorophenyl)-4-(pyridin-4-yl)-1H-imidazol-2-yl)phenol |
phenol, 4-(4-(4-fluorophenyl)-5-(4-pyridinyl)-1h-imidazol-2-yl)- |
4-4-(4-fluorophenyl)-5-pyridin-4-yl-1,3-dihydroimidazol-2-ylidene-1-cyclohexa-2,5-dienone |
SMR001230795 |
SB 202190, Immobilized |
InSolution™ SB 202190 |
Kinome_3708 |
Tocris-1264 |
BiomolKI_000051 |
Lopac-S-7067 |
biotinylated SB202190 |
BiomolKI2_000057 |
Lopac0_000173 |
BMK1-F3 |
BSPBio_001106 |
KBioGR_000446 |
KBioSS_000446 |
cc-468 |
MLS002153419 |
MLS006010258 |
SCHEMBL158854 |
CHEMBL278041 |
GTPL4307 |
SCHEMBL1230814 |
DTXSID7041120 |
BDBM13531 |
CHEBI:92952 |
KBio2_000446 |
KBio2_003014 |
KBio2_005582 |
KBio3_000831 |
KBio3_000832 |
AOB2557 |
EX-A313 |
SYN1073 |
4o77 |
Bio1_000479 |
Bio1_000968 |
Bio1_001457 |
Bio2_000393 |
Bio2_000873 |
HMS1362H07 |
HMS1792H07 |
HMS1990H07 |
HMS2235B15 |
HMS3229M22 |
HMS3244I13 |
HMS3244I14 |
HMS3244J13 |
HMS3260D07 |
HMS3267J19 |
HMS3371G22 |
HMS3403H07 |
HMS3412C22 |
HMS3654O15 |
HMS3674G07 |
HMS3676C22 |
BCP00675 |
Tox21_500173 |
BDBM50044784 |
NSC789969 |
s1077 |
ZINC14951176 |
ZINC89221712 |
AKOS005146403 |
AKOS026750414 |
AKOS037643394 |
ACN-053035 |
CCG-100655 |
CCG-204268 |
CS-0141 |
LP00173 |
NSC-789969 |
QC-9800 |
SDCCGSBI-0050161.P003 |
4-4-(4-fluorophenyl)-5-pyridin-4-yl-1,3-dihydroimidazol-2-ylidenecyclohexa-2,5-dien-1-one |
IDI1_002148 |
SMP2_000191 |
NCGC00015962-01 |
NCGC00015962-02 |
NCGC00015962-03 |
NCGC00015962-04 |
NCGC00015962-05 |
NCGC00015962-06 |
NCGC00015962-07 |
NCGC00015962-08 |
NCGC00015962-09 |
NCGC00015962-10 |
NCGC00015962-27 |
NCGC00025089-01 |
NCGC00025089-02 |
NCGC00025089-03 |
NCGC00025089-04 |
NCGC00025089-05 |
NCGC00025089-06 |
NCGC00260858-01 |
AC-32866 |
AS-16228 |
HY-10295 |
EU-0100173 |
FT-0743934 |
SW218110-2 |
X7402 |
EC-000.2317 |
F17395 |
S 7067 |
SB 202190, >=98% (HPLC) |
121S307 |
SR-01000075720 |
SR-01000597393 |
J-513574 |
J-690315 |
SR-01000075720-1 |
SR-01000597393-1 |
BRD-K54330070-001-05-5 |
BRD-K54330070-001-07-1 |
InSolution SB 202190 - CAS 152121-30-7 |
Q27088696 |
Q27164687 |
SB 202190 - CAS 152121-30-7 |
4-4-(4-Fluoro-phenyl)-5-pyridin-4-yl-1H-imidazol-2-yl-phenol |
4-4-(4-fluorophenyl)-5-(4-pyridyl)-1H-imidazol-2-ylphenol |
4-4-(4-fluorophenyl)-5-pyridin-4-yl-1H-imidazol-2-ylphenol |
4-4-(4-Fluorphenyl)-5-(4-pyridinyl)-1H-imidazol-2-ylphenol |
FHPI|||4-(4-(4-Fluorophenyl)-5-(pyridin-4-yl)-1H-imidazol-2-yl)phenol |
4-4-(4-fluorophenyl)-5-(4-pyridyl)-4-imidazolin-2-ylidenecyclohexa-2,5-dien-1-one |
2RE |
Experimental Data
152121-30-7
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | -3 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
152121-30-7
Statistics Data
152121-30-7
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -3 | 1 | 1 |
Statistics Data Visualization
152121-30-7
